A61P 7 - Drugs for disorders of the blood or the extracellular fluid

Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
10/2011
10/11/2011	CA2472479C Deazapurines and uses thereof
10/11/2011	CA2453978C Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitors
10/11/2011	CA2447663C Composition and use of substances for the stabilization of sulphur-containing amino acids
10/11/2011	CA2394862C Tnf-alpha antagonist and lfa-1 antagonist for treating lfa-1 or tnf-alpha mediated disorder
10/06/2011	WO2011122647A1 Hemoglobin material intermediate product used in artificial oxygen carrier manufacturing
10/06/2011	WO2011121354A1 The therapeutic use of tetrathiomolybdate
10/06/2011	WO2011120118A1 Method for preparing matrix micro-particles of copaífera langsdorffii (aerial parts) and for isolating the active principles therein; thus prepared analgesic, anti-spasmodic, anti-inflammatory, diuretic and antiseptic micro-particles and compounds with anti-lithiasis activity (renal calculi), formulations, products and uses thereof
10/06/2011	WO2011089618A3 Drug-eluting insert able medical device for treating acute myocardial infarction, thrombus containing lesions and saphenous- vein graft lesions
10/06/2011	US20110247087 Regulation of endogenous gene expression in cells using zinc finger proteins
10/06/2011	US20110245332 Injectable formulations of taxanes for cad treatment
10/06/2011	US20110245273 Novel aliphatically substituted pyrazolopyridines, and the use thereof
10/06/2011	US20110245251 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
10/06/2011	US20110245248 Isoquinoline derivatives
10/06/2011	US20110245222 Methods for Using Carboxamide, Sulfonamide and Amine Compounds
10/06/2011	US20110245216 Use of dhea derivatives for enhancing physical performance
10/06/2011	US20110245209 Pyridopyrimidine derivatives and methods of use thereof
10/06/2011	US20110245200 Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
10/06/2011	US20110245196 Novel sulfated oligosaccharide derivatives
10/06/2011	US20110245176 Novel peptides that bind to the erythropoietin receptor
10/06/2011	US20110245172 Biocompatible oligomer-polymer compositions
10/06/2011	US20110244564 Cystine knot molecules
10/06/2011	US20110244017 Absorbable Coating For Implantable Device
10/06/2011	US20110244001 System and method for the release of nitric oxide using nanoscale media
10/06/2011	US20110243938 Methods to Reduce B-Helper T Cells to Treat Autoimmune Diseases
10/06/2011	US20110243930 Compositions and methods for the treatment of immune related diseases
10/06/2011	US20110243910 mammalian rna dependent rna polymerase
10/06/2011	US20110243890 Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells With a Virus
10/05/2011	EP2371830A1 Method for producing diamine derivative
10/05/2011	EP2371361A1 Methods to mobilize progenitor/stem cells
10/05/2011	EP2370469A2 Anti-rhd monoclonal antibodies
10/05/2011	EP2370457A2 Compositions and methods using alpha beta-crystallin in protecting the myocardium from ischemia/reperfusion injury
10/05/2011	EP2173744B1 Substituted (oxazolidinon-5-yl-methyl) -2-thiophene-carboxamides and use thereof in the field of blood coagulation
10/05/2011	EP1787991B1 PYRROLO[2,3-c]PYRIDINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE
10/05/2011	EP1510216B1 Antithrombogenic ceramic composition and article containing the same
10/05/2011	EP1377276B1 Timed pulse release composition
10/05/2011	CN1817883B New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound
10/05/2011	CN102209718A Carbamate compound or salt thereof
10/05/2011	CN102209546A Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy
10/05/2011	CN102209545A Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy
10/05/2011	CN102209544A Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved safety profile over conventional warfarin therapy
10/05/2011	CN102206277A Antibodies that bind human interleukin-18 and methods of making and using
10/05/2011	CN102206276A Humanized antibodies derived from DD-3B6/22, specific for the D-dimer fragment of fibrin
10/05/2011	CN102205115A Application of ulinastatin serving as rescue auxiliary medicament for toxic shock caused by acute abdomen
10/05/2011	CN102205113A Novel application of Jingzhaotoxin
10/05/2011	CN102205092A Chinese medicinal composition for treating abdominal dropsy of large animals and application method thereof
10/05/2011	CN102205065A Clot-absorbing and swelling-dispersing preparation
10/05/2011	CN102205051A Notoginseng root hematogenic medicament and preparation method thereof
10/05/2011	CN102205000A Callicarpa nudiflora Hook. et Arn. extract, preparation method and application thereof
10/05/2011	CN102204999A Method for measuring content of luteolin in callicarpa nudiflora preparation
10/05/2011	CN102204998A Method for measuring content of verbascoside in callicarpa nudiflora preparation
10/05/2011	CN102204967A Preparation method for safflower care-free tablet
10/05/2011	CN102204951A Method for extracting active components from licorice
10/05/2011	CN102204949A Method for preparing dalbergia odorifera seed extract and quickly screening anticoagulant activity of dalbergia odorifera seed extract
10/05/2011	CN102204945A Extraction method of herba cirsii japonici carbonisatum general flavone liquid
10/05/2011	CN102204944A Preparation method of raw materials of Xuesaitong (thrombus removal) injection
10/05/2011	CN102204940A Evening primrose oil microcapsule and pulverization method
10/05/2011	CN102204937A Pyrola extract and preparation method and application thereof
10/05/2011	CN102204892A Gingko flavanone aglycone dropping pills and preparation method thereof
10/05/2011	CN102204890A Eptifibatide lyophilized powder injection with superior rehydration
10/05/2011	CN102204879A Preparation method of ginkgolide B solid dispersion
10/05/2011	CN101972351B Traditional Chinese medicine for treating thrombocytopenia and Henoch-Schonlein purpura
10/05/2011	CN101716221B Dripping pill for increasing leucocyte
10/05/2011	CN101703691B Chinese medicinal composition for treating gastrointestinal ulcer and hemorrhage, and preparation method thereof
10/05/2011	CN101669954B Ferrous fumarate folic acid dispersible tablet and preparation method thereof
10/05/2011	CN101637477B Drug composite containing troxerutin and ADP receptor antagonist
10/05/2011	CN101549027B Drug for treating thrombopenia
10/05/2011	CN101505766B Preventive remedial therapeutic agent for phosphorus impairment, oral agent for adsorbing phosphate ion contained in food, beverage and chemical, and process for producing them
10/05/2011	CN101327236B Use of pseudo-ginseng saponin component for treating septicemia
10/05/2011	CN101268848B Dew concentration beverage
10/05/2011	CN101152285B Pharmaceutical composition of snakegourd fruit and whitethorn leaf
10/04/2011	US8030296 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase
10/04/2011	US8030275 Methods for treating obesity using fibroblast growth factor-like polypeptides
10/04/2011	US8030074 In vivo incorporation of unnatural amino acids
10/04/2011	US8029793 Anticancer agents; rheumatic diseases; osteoporosis; antiinflammatory agents; cloning genes
10/04/2011	CA2478099C Inhibitors
10/04/2011	CA2438520C Phthalazinone-piperidino-derivatives as pde4 inhibitors
09/2011
09/29/2011	WO2011120040A2 Thrombin inhibiting compositions
09/29/2011	WO2011118818A1 Amidinoaneline derivative
09/29/2011	WO2011118759A1 Benzanilide derivative
09/29/2011	WO2011118672A1 Plasma kallikrein inhibitor
09/29/2011	WO2011117305A1 Azo compounds reducing formation and toxicity of amyloid beta aggregation intermediates
09/29/2011	WO2011117225A1 Fe(iii) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias
09/29/2011	WO2011116909A1 Pharmaceutical compositions containing substituted 6-deoxy-6-sulfanylcyclodextrin
09/29/2011	WO2011044452A3 Methods and compositions for amelioration of autoimmune disease using fusion proteins of anti-dendritic cell receptor antibody to peptide sequences
09/29/2011	WO2010132370A3 Soluble tlt-1 for the treatment and diagnosis of sepsis
09/29/2011	US20110238000 Polymer-conjugated albumin hydrogels for controlled release of therapeutic agents
09/29/2011	US20110237672 Use of a cysteine-containing substance to increase the ventilatory activity and erythropoietin production
09/29/2011	US20110237663 Method for treating Philadelphia-negative myeloproliferative syndromes
09/29/2011	US20110237655 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use
09/29/2011	US20110237651 Treatment of erythropoietin (epo) related diseases by inhibition of natural antisense transcript to epo
09/29/2011	US20110237573 N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as wnt signaling modulators
09/29/2011	US20110237570 Substituted imidazo[1,2-b]pyridazine derivatives, pharmaceutical compositions, and methods of use as beta-secretase inhibitors
09/29/2011	US20110237539 Spinning Solution and Method for Manufacturing Biomaterial Fibers
09/29/2011	US20110237512 Methods for Treating Bleeding Disorders Using Sulfated Polysaccharides
09/29/2011	US20110237511 EP4 Receptor Agonist, Compositions and Methods Thereof
09/29/2011	US20110237508 Peptide Formulations and Uses Thereof
09/29/2011	US20110237494 Use of peptidic vasopression receptor agonists
09/29/2011	US20110236474 Pharmaceutical Compositions of Selective Factor Xa Inhibitors for Oral Administration
09/29/2011	US20110236433 Wound care device
09/29/2011	US20110236405 Coagulation factor modulation for controlling transplant organ size

1 ... 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 ... 671